[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100601641":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":18,"centralContacts":30,"locations":10,"responsibleParty":35,"collaborators":10,"id":39,"slug":10,"hasResults":40,"nctId":41,"briefTitle":42,"officialTitle":42,"acronym":10,"eligibilityCriteria":43,"healthyVolunteers":44,"sex":45,"minAge":10,"maxAge":10,"enrollmentInfo":46,"targetDuration":49,"studyType":50,"phases":10,"briefSummary":51,"conditions":52,"keywords":55,"overallStatus":59,"whyStopped":10,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":64,"completionDateStruct":66,"leadSponsor":68,"locationsCount":10},{"fullName":5,"class":6},"Assiut University","OTHER",[8,12,15],{"label":9,"type":10,"description":11,"interventionNames":10},"all patients group",null,"peripheral blood samples of 28 acute lymphoblastic leukemia patients",{"label":13,"type":10,"description":14,"interventionNames":10},"cll patients","peripheral blood samples of 28 chronic lymphocytic leukemia patients",{"label":16,"type":10,"description":17,"interventionNames":10},"control group","peripheral blood samples of 28 control",[19,22,25,27],{"name":20,"affiliation":5,"role":21},"Sohair m Farghaly, professor","STUDY_DIRECTOR",{"name":23,"affiliation":5,"role":24},"Taghred m Kamal El-Din, asst. prof","STUDY_CHAIR",{"name":26,"affiliation":5,"role":24},"Hebatallah Abdellatif, asst. prof",{"name":28,"affiliation":5,"role":29},"safaa a omran, asst. lect.","PRINCIPAL_INVESTIGATOR",[31],{"name":28,"role":32,"phone":33,"phoneExt":10,"email":34},"CONTACT","+201060284142","safaaali1491994@aun.edu.eg",{"type":36,"investigatorFullName":37,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"SPONSOR_INVESTIGATOR","Safaa Ali","assisstant lecturer","100601641",false,"NCT07113132","Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia","Inclusion Criteria:\n\n* Patients with acute lymphocytic leukemia or chronic lymphocytic leukemia of both genders at any age.\n\nExclusion Criteria:\n\n* Patients with any other type of malignancies",true,"ALL",{"count":47,"type":48},84,"ESTIMATED","6 Months","OBSERVATIONAL","aim of the work\n\n1. To evaluate the presence of SF3B1-K700E mutation in acute lymphoblastic leukemia and chronic lymphocytic leukemia.\n2. To determine the correlation between the presence of SF3B1-K700E mutation with other laboratory findings.",[53,54],"Acute Lymphoblastic Leukemia ALL","Chronic Lymphocytic Leukemia (CLL)",[56,57,58],"sf3b1 mutation","all","cll","NOT_YET_RECRUITING","2025-08-06",{"date":62,"type":63},"2025-08-08","ACTUAL",{"date":65,"type":48},"2025-08-01",{"date":67,"type":48},"2027-07-01",{"name":37,"class":6}]